Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 ILa | 0.00% | +7.41% | +11.54% |
05-12 | Transcript : Can-Fite BioPharma Ltd. - Special Call | |
05-09 | Can-Fite BioPharma Ltd. Announces FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Bearish |
Resistance | 3.000 | 3.000 | 3.120 |
Spread/Res. | -3.33% | -3.33% | -7.05% |
Spread/Supp. | +11.54% | +16.00% | +16.00% |
Support | 2.600 | 2.500 | 2.500 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- CANF Stock
- Charts Can-Fite BioPharma Ltd.